Bay Harbor Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Bay Harbor Wealth Management's HALO Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its Halozyme (HALO) stake by 32% in Q2 2026, buying an estimated $409 and bringing the position to 25 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #656.
Bay Harbor Wealth Management first reported a position in HALO in Q4 2018 and has held it in 16 quarters since. The position peaked at $51K in Q4 2020. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Bay Harbor Wealth Management held 25 shares of Halozyme worth $1.96K as of Q2 2026.
- Bay Harbor Wealth Management bought 6 Halozyme shares in Q2 2026, an estimated $409.
- Halozyme made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #656 holding.
- Bay Harbor Wealth Management first reported a position in Halozyme in Q4 2018 and has held it in 16 quarters since.
- Bay Harbor Wealth Management's Halozyme position peaked at $51K in Q4 2020.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.